Longitudinal dynamics of Epstein-Barr virus-specific cytotoxic T lymphocytes during posttransplant lymphoproliferative disorder

被引:27
作者
Kuzushima, K
Kimura, H
Hoshino, Y
Yoshimi, A
Tsuge, I
Horibe, K
Morishima, T
Tsurumi, T
Kojima, S
机构
[1] Aichi Canc Ctr, Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi 4648681, Japan
[2] Nagoya Univ, Sch Med, Dept Pediat Dev Pediat, Nagoya, Aichi 466, Japan
[3] Nagoya Univ, Sch Med, Dept Hlth Sci, Nagoya, Aichi 466, Japan
基金
日本学术振兴会;
关键词
D O I
10.1086/315791
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epstein-Barr virus (EBV)-associated lymphoproliferative disorder (LPD) is a serious complication after allogeneic bone marrow transplantation (BMT). Dynamics of EBV-specific cytotoxic T lymphocytes (CTL), which are important in controlling EBV during the LPD, have not been fully elucidated A patient with Wiskot-Aldrich's syndrome was diagnosed as suffering from LPD on day 47 after BMT. Fluorescence-activated cell sorter (FACS) analysis for interferon-gamma production revealed that >70% of the patient's CD8(+) T cells were EBV specific. The patient's lymphocytes were directly cytotoxic to donor-derived EBV-positive lymphoblastoid cells, which was blocked by an anti-class I antibody. EBV-specific CD8(+) T cell counts declined in parallel with EBV genome load, and full recovery of LPD was obtained with relaxation of immunosuppressive drags. The results illustrate longitudinal dynamics of EBV-specific CTL during the posttransplant LPD; they also illustrate the advantages of using FAGS analysis for EBV-specific CTL to make decisions about treatment.
引用
收藏
页码:937 / 940
页数:4
相关论文
共 15 条
[11]   Rapid determination of Epstein-Barr virus-specific CD8+ T-cell frequencies by flow cytometry [J].
Kuzushima, K ;
Hoshino, Y ;
Fujii, K ;
Yokoyama, N ;
Fujita, M ;
Kiyono, T ;
Kimura, H ;
Morishima, T ;
Morishima, Y ;
Tsurumi, T .
BLOOD, 1999, 94 (09) :3094-3100
[12]   INFUSIONS OF DONOR LEUKOCYTES TO TREAT EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
PAPADOPOULOS, EB ;
LADANYI, M ;
EMANUEL, D ;
MACKINNON, S ;
BOULAD, F ;
CARABASI, MH ;
CASTROMALASPINA, H ;
CHILDS, BH ;
GILLIO, AP ;
SMALL, TN ;
YOUNG, JW ;
KERNAN, NA ;
OREILLY, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (17) :1185-1191
[13]   Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection [J].
Rickinson, AB ;
Moss, DJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :405-431
[14]  
RICKINSON AB, 1996, FIELDS VIROLOGY, V2, P2397
[15]   USE OF GENE-MODIFIED VIRUS-SPECIFIC T-LYMPHOCYTES TO CONTROL EPSTEIN-BARR-VIRUS-RELATED LYMPHOPROLIFERATION [J].
ROONEY, CM ;
SMITH, CA ;
NG, CYC ;
LOFTIN, S ;
LI, CF ;
KRANCE, RA ;
BRENNER, MK ;
HESLOP, HE .
LANCET, 1995, 345 (8941) :9-13